KREMEN2
Basic information
Region (hg38): 16:2964216-2968380
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KREMEN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 39 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 2 | 1 |
Variants in KREMEN2
This is a list of pathogenic ClinVar variants found in the KREMEN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-2964570-T-G | not specified | Uncertain significance (Dec 13, 2022) | ||
16-2964582-G-C | not specified | Uncertain significance (Jul 05, 2022) | ||
16-2964584-G-A | not specified | Uncertain significance (Dec 23, 2022) | ||
16-2964859-G-T | not specified | Uncertain significance (Jan 10, 2023) | ||
16-2964897-C-A | not specified | Uncertain significance (Oct 29, 2021) | ||
16-2964927-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
16-2964997-A-C | not specified | Uncertain significance (Dec 14, 2024) | ||
16-2965005-T-G | not specified | Uncertain significance (Jan 21, 2025) | ||
16-2966150-G-A | not specified | Uncertain significance (Jul 19, 2022) | ||
16-2966174-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
16-2966183-A-G | not specified | Uncertain significance (Dec 26, 2023) | ||
16-2966213-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
16-2966343-G-A | not specified | Uncertain significance (Apr 26, 2024) | ||
16-2966376-G-T | not specified | Uncertain significance (Nov 07, 2024) | ||
16-2966377-C-A | not specified | Uncertain significance (Nov 07, 2024) | ||
16-2966408-G-A | not specified | Uncertain significance (Oct 07, 2024) | ||
16-2966649-G-T | Ependymoma | Uncertain significance (Dec 29, 2017) | ||
16-2966660-G-A | not specified | Uncertain significance (Dec 07, 2024) | ||
16-2966682-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
16-2966955-T-C | not specified | Uncertain significance (Jul 09, 2024) | ||
16-2966993-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
16-2967040-G-C | not specified | Uncertain significance (Apr 07, 2022) | ||
16-2967050-C-T | not specified | Uncertain significance (Feb 12, 2025) | ||
16-2967053-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
16-2967062-C-A | not specified | Uncertain significance (Aug 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KREMEN2 | protein_coding | protein_coding | ENST00000303746 | 9 | 4440 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000372 | 0.955 | 125569 | 0 | 12 | 125581 | 0.0000478 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.51 | 178 | 245 | 0.728 | 0.0000156 | 2836 |
Missense in Polyphen | 62 | 96.435 | 0.64292 | 990 | ||
Synonymous | -0.559 | 122 | 114 | 1.07 | 0.00000812 | 991 |
Loss of Function | 1.83 | 10 | 18.5 | 0.541 | 9.22e-7 | 210 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000696 | 0.0000616 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000273 | 0.0000264 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000138 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for Dickkopf proteins. Cooperates with DKK1/2 to inhibit Wnt/beta-catenin signaling by promoting the endocytosis of Wnt receptors LRP5 and LRP6. Plays a role in limb development; attenuates Wnt signaling in the developing limb to allow normal limb patterning and can also negatively regulate bone formation. {ECO:0000250|UniProtKB:Q8K1S7}.;
- Pathway
- WNT-Ncore;Signaling by WNT;Signal Transduction;wnt signaling pathway;segmentation clock;multi-step regulation of transcription by pitx2;wnt lrp6 signalling;inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Wnt Canonical;Wnt signaling network;TCF dependent signaling in response to WNT;Wnt Mammals;Presenilin action in Notch and Wnt signaling
(Consensus)
Recessive Scores
- pRec
- 0.106
Haploinsufficiency Scores
- pHI
- 0.165
- hipred
- Y
- hipred_score
- 0.740
- ghis
- 0.420
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.747
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kremen2
- Phenotype
- normal phenotype; limbs/digits/tail phenotype; skeleton phenotype;
Gene ontology
- Biological process
- Wnt signaling pathway;negative regulation of ossification;limb development;negative regulation of canonical Wnt signaling pathway
- Cellular component
- plasma membrane;integral component of membrane;early endosome membrane
- Molecular function